| Prion Protein (PrP) | |
|---|---|
| Gene | PRNP |
| UniProt | P04156 |
| PDB | 1QLX, 1QM0, 2KUN, 4KML |
| Mol. Weight | 27–30 kDa (PrPC), variable (PrPSc aggregates) |
| Localization | Cell surface (GPI-anchored), extracellular |
| Family | Prion protein family |
| Diseases | Creutzfeldt-Jakob Disease, Fatal Familial Insomnia, Gerstmann-Straussler-Scheinker Syndrome, Kuru |
Prion Protein (Prp) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Prion Protein (PrP), encoded by the [PRNP--TEMP--/genes)--FIX-- gene, is a glycosylphosphatidylinositol (GPI)-anchored protein predominantly expressed in the central nervous system. It is the central player in prion diseases, a unique class of fatal neurodegenerative disorders that include [Creutzfeldt-Jakob Disease--TEMP--/diseases)--FIX-- (CJD), [Fatal Familial Insomnia--TEMP--/diseases)--FIX-- (FFI), [Gerstmann-Sträussler-Scheinker Syndrome--TEMP--/diseases)--FIX-- (GSS), and kuru[1].
The prion protein exists in two isoforms: the normal cellular form (PrPC) and the disease-causing scrapie form (PrPSc). The fundamental difference between these isoforms lies not in their amino acid sequence, but in their three-dimensional conformation. PrPC adopts a predominantly α-helical structure, while PrPSc is rich in β-sheet content, enabling aggregation and formation of infectious amyloid fibrils[2].
The prion protein consists of several distinct structural domains:
The cellular form PrPC has been characterized by X-ray crystallography and NMR spectroscopy. The C-terminal domain contains:
Available PDB structures include 1QLX, 1QM0, 2KUN, and 4KML. The protein's three-dimensional structure can also be explored via the AlphaFold Protein Structure Database[3].
A remarkable feature of prion diseases is strain diversity. The same amino acid sequence of PrP can adopt multiple distinct conformations, each encoding different biological properties including incubation period, clinical phenotype, and neuropathological lesions. This strain diversity is encoded in the three-dimensional structure of PrPSc and can be maintained upon passage in vivo[4].
The physiological function of PrPC remains incompletely understood, but research has implicated it in several important cellular processes:
The octarepeat region of PrP binds copper ions (Cu2+) with high affinity, suggesting a role in copper homeostasis. PrP may function as a copper reductase or contribute to cellular copper uptake[5].
PrPC exhibits anti-apoptotic properties through interaction with various cellular pathways. It can:
PrP is highly concentrated at synapses, where it may contribute to:
PrPC interacts with multiple ligands and receptors including:
These interactions suggest roles in cell signaling, particularly in neuronal survival pathways[6].
Studies have shown that PrP is important for oligodendrocyte function and myelin maintenance. PrP-deficient mice develop late-onset demyelination.
The scrapie isoform PrPSc is the infectious, misfolded form that drives neurodegeneration. The conversion from PrPC to PrPSc involves a conformational change that increases β-sheet content and creates an aggregation-prone protein.
Template-mediated conversion: PrPSc acts as a template to convert normal PrPC into additional PrPSc, creating a self-propagating cascade
Amyloid fibril formation: PrPSc aggregates into insoluble amyloid fibrils that deposit throughout the brain
Neuronal dysfunction: Loss of PrPC function combined with toxic gain-of-function from PrPSc leads to:
Spongiform degeneration: Vacuolation of brain tissue is a hallmark of prion diseases, resulting from synaptic loss and neuronal death
Neuroinflammation: Activated microglia and astrocytes contribute to disease progression[7]
The polymorphism at codon 129 of PRNP (methionine vs. valine) dramatically influences susceptibility to prion diseases:
Prion Protein (PrP) represents an important therapeutic target. Multiple drug development strategies are being explored:
The study of Prion Protein (Prp) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Last updated: 2026-03-06